Posts
-
Sanguino Honored by American Medical Women’s Association
Sandra Sanguino, ’93 MD, MPH, associate dean for Student Affairs, has received the Exceptional Mentor Award from the American Medical Women’s Association.
-
Evaluating A Novel Chemo-free Combination Therapy for Lymphocytic Leukemia
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
-
Novel Biomarker Predicts Treatment Response in Chronic Leukemia
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.